Myriem Boufraqech

2.3k total citations
45 papers, 1.8k citations indexed

About

Myriem Boufraqech is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Myriem Boufraqech has authored 45 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 19 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Cancer Research. Recurrent topics in Myriem Boufraqech's work include Thyroid Cancer Diagnosis and Treatment (15 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Adrenal and Paraganglionic Tumors (7 papers). Myriem Boufraqech is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (15 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Adrenal and Paraganglionic Tumors (7 papers). Myriem Boufraqech collaborates with scholars based in United States, France and Morocco. Myriem Boufraqech's co-authors include Naris Nilubol, Electron Kebebew, Dhaval Patel, Lisa Zhang, Urbain Weyemi, Lisa Zhang, Monique Talbot, Corinne Dupuy, Françoise Courtin and Min Shen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Myriem Boufraqech

44 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Myriem Boufraqech United States 23 1.1k 540 450 366 186 45 1.8k
Gengyin Zhou China 26 1.0k 0.9× 366 0.7× 199 0.4× 545 1.5× 223 1.2× 61 1.8k
Johann Zimmermann Switzerland 23 1.2k 1.1× 427 0.8× 290 0.6× 764 2.1× 113 0.6× 41 1.9k
Ouchen Wang China 28 1.3k 1.2× 841 1.6× 558 1.2× 455 1.2× 315 1.7× 101 2.3k
Takako Asano Japan 27 1.3k 1.2× 469 0.9× 158 0.4× 378 1.0× 219 1.2× 84 2.1k
Eunju Hurh United States 20 990 0.9× 333 0.6× 506 1.1× 210 0.6× 538 2.9× 43 2.2k
Carmen Priolo United States 20 930 0.9× 498 0.9× 155 0.3× 312 0.9× 101 0.5× 35 1.4k
Fabiola Moretti Italy 25 1.1k 1.0× 270 0.5× 222 0.5× 650 1.8× 95 0.5× 59 1.7k
Tadaaki Taniguchi Japan 18 738 0.7× 352 0.7× 306 0.7× 428 1.2× 161 0.9× 31 1.3k
Antonella Verrienti Italy 24 652 0.6× 287 0.5× 1.0k 2.3× 310 0.8× 363 2.0× 74 1.8k

Countries citing papers authored by Myriem Boufraqech

Since Specialization
Citations

This map shows the geographic impact of Myriem Boufraqech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myriem Boufraqech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myriem Boufraqech more than expected).

Fields of papers citing papers by Myriem Boufraqech

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myriem Boufraqech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myriem Boufraqech. The network helps show where Myriem Boufraqech may publish in the future.

Co-authorship network of co-authors of Myriem Boufraqech

This figure shows the co-authorship network connecting the top 25 collaborators of Myriem Boufraqech. A scholar is included among the top collaborators of Myriem Boufraqech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myriem Boufraqech. Myriem Boufraqech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Jiangnan, et al.. (2026). Dual targeting of BRAFV600E and ferroptosis results in synergistic anticancer activity via iron overload and enhanced oxidative stress. Journal of Experimental & Clinical Cancer Research. 45(1). 34–34.
2.
Liu, Yue, Þorkell Andrésson, William C. Reinhold, et al.. (2024). Metabolism‐focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer. Molecular Carcinogenesis. 63(6). 1024–1037. 1 indexed citations
3.
Liu, Yue, et al.. (2022). Histone H2AX promotes metastatic progression by preserving glycolysis via hexokinase-2. Scientific Reports. 12(1). 59–63. 6 indexed citations
4.
Ghosh, Chandrayee, Suresh Kumar, Yevgeniya Kushchayeva, et al.. (2020). A Combinatorial Strategy for Targeting BRAF V600E-Mutant Cancers with BRAFV600E Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib). Clinical Cancer Research. 26(8). 2022–2036. 18 indexed citations
5.
Nilubol, Naris, et al.. (2020). New Therapies for Advanced Thyroid Cancer. Frontiers in Endocrinology. 11. 82–82. 165 indexed citations
6.
Weyemi, Urbain, Bindu D. Paul, Adarsha P. Malla, et al.. (2019). Histone H2AX promotes neuronal health by controlling mitochondrial homeostasis. Proceedings of the National Academy of Sciences. 116(15). 7471–7476. 24 indexed citations
7.
Thakur, Shilpa, Kelli Gaskins, Vasyl Vasko, et al.. (2018). Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer In Vitro and In Vivo. Clinical Cancer Research. 24(16). 4030–4043. 108 indexed citations
8.
Kotian, Shweta, Lisa Zhang, Myriem Boufraqech, et al.. (2017). Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases. Clinical Cancer Research. 23(17). 5044–5054. 63 indexed citations
9.
Boufraqech, Myriem, Lisa Zhang, Naris Nilubol, et al.. (2016). Lysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human Cancers. Clinical Cancer Research. 22(17). 4491–4504. 54 indexed citations
10.
Satoh, Kei, Lisa Zhang, Yaqin Zhang, et al.. (2016). Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma. Clinical Cancer Research. 22(14). 3458–3466. 77 indexed citations
11.
Weyemi, Urbain, Christophe E. Redon, Daisuke Maeda, et al.. (2016). The histone variant H2A.X is a regulator of the epithelial–mesenchymal transition. Nature Communications. 7(1). 10711–10711. 61 indexed citations
12.
Boufraqech, Myriem, Joanna Kłubo-Gwieździńska, & Electron Kebebew. (2016). MicroRNAs in the thyroid. Best Practice & Research Clinical Endocrinology & Metabolism. 30(5). 603–619. 45 indexed citations
13.
Gara, Sudheer Kumar, Yonghong Wang, Dhaval Patel, et al.. (2015). Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples. Nucleic Acids Research. 43(19). 9327–9339. 25 indexed citations
14.
Boufraqech, Myriem, Naris Nilubol, Lisa Zhang, et al.. (2014). miR30a Inhibits LOX Expression and Anaplastic Thyroid Cancer Progression. Cancer Research. 75(2). 367–377. 65 indexed citations
15.
Patel, Dhaval, Ryan J. Ellis, Myriem Boufraqech, et al.. (2014). Analysis of IGF and IGFBP as Prognostic Serum Biomarkers for Adrenocortical Carcinoma. Annals of Surgical Oncology. 21(11). 3541–3547. 9 indexed citations
16.
Mehta, Amit, Dhaval Patel, Avi Z. Rosenberg, et al.. (2014). Hyperparathyroidism-jaw tumor syndrome: Results of operative management. Surgery. 156(6). 1315–1325. 58 indexed citations
17.
Boufraqech, Myriem, Dhaval Patel, Yin Xiong, & Electron Kebebew. (2013). Diagnosis of thyroid cancer: state of art. Expert Opinion on Medical Diagnostics. 7(4). 331–342. 20 indexed citations
18.
Patel, Dhaval, Myriem Boufraqech, Meenu Jain, et al.. (2013). MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors. Surgery. 154(6). 1224–1229. 74 indexed citations
19.
Weyemi, Urbain, Myriem Boufraqech, Françoise Courtin, et al.. (2011). ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence. Oncogene. 31(9). 1117–1129. 240 indexed citations
20.
Fortunato, Rodrigo S., Myriem Boufraqech, Urbain Weyemi, et al.. (2010). Functional Consequences of Dual Oxidase-Thyroperoxidase Interaction at the Plasma Membrane. The Journal of Clinical Endocrinology & Metabolism. 95(12). 5403–5411. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gengyin Zhou Breakdown of academic impact, for papers by Johann Zimmermann Breakdown of academic impact, for papers by Ouchen Wang Breakdown of academic impact, for papers by Takako Asano Breakdown of academic impact, for papers by Eunju Hurh Breakdown of academic impact, for papers by Carmen Priolo Breakdown of academic impact, for papers by Fabiola Moretti Breakdown of academic impact, for papers by Tadaaki Taniguchi Breakdown of academic impact, for papers by Antonella Verrienti
Rankless by CCL
2026